Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
4 holders
Ownership
Activity
Fundamentals
2021 Q3
18 of 52 quarters
Total Value
$1.78B
Total Shares
25.54M
Net Share Change
+5.60M
Activity
3 buying
1 selling
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$1.76B
25.14M
1.9%
ADD
+5.68M
(+29.2%)
Dodge & Cox Stock Fund
$1.76B
25.14M shares
ADD
+5.68M
(+29.2%)
Matrix Asset Advisors
$24.56M
351.6K
3.5%
ADD
+1.6K
(+0.5%)
Matrix Asset Advisors
$24.56M
351.6K shares
ADD
+1.6K
(+0.5%)
Bridgewater Associates LP
$3.12M
44.6K
0.0%
TRIM
-82.1K
(-64.8%)
Bridgewater Associates LP
$3.12M
44.6K shares
TRIM
-82.1K
(-64.8%)
Pzena Investment Management
$567.0K
8.1K
0.0%
ADD
+3.7K
(+83.6%)
Pzena Investment Management
$567.0K
8.1K shares
ADD
+3.7K
(+83.6%)
GILD — Gilead Sciences, Inc. - FilingSpy